What is the stepwise approach, including drug dosing, for managing an acute migraine attack in the emergency department?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Stepwise Management of Acute Migraine in the Emergency Department

Start with IV prochlorperazine 10 mg or IV metoclopramide 10 mg as first-line therapy for adults presenting to the ED with acute migraine requiring parenteral treatment. 1

First-Line Therapy (Choose One)

The 2025 American Headache Society guideline establishes clear first-line options based on the highest quality evidence:

Dopamine Antagonists (Preferred)

  • Prochlorperazine IV: 10 mg (Level A - must offer) 1
  • Metoclopramide IV: 10 mg (Level B - should offer) 1, 2

These antiemetics work through dopamine antagonism and have multiple Class I studies demonstrating efficacy. They simultaneously treat headache and associated nausea, making them ideal for the ED setting 2.

Alternative First-Line Options

  • Dexketoprofen IV: 50 mg (Level B - should offer) 1
  • Ketorolac IV: 30 mg (Level B - should offer) 1
  • Sumatriptan SC: 6 mg (Level B - should offer) 1
  • Greater Occipital Nerve Block (GONB) (Level A - must offer) 1
  • Supraorbital Nerve Block (SONB) (Level B - should offer) 1

Common Pitfall: Avoid starting with opioids. Hydromorphone IV is rated Level A - must NOT offer due to lack of efficacy and risk of medication overuse headache 1.

Second-Line Therapy (If First-Line Fails)

When patients fail to improve after 30-60 minutes with first-line treatment:

Reasonable Options

  • IV NSAIDs (ketorolac 30 mg or dexketoprofen 50 mg if not already used) 3
  • IV acetaminophen: 1000 mg (though rated "may not offer" as monotherapy) 1
  • Chlorpromazine IV: 0.1 mg/kg (max 37.5 mg) (Level C - may offer) 1
  • Valproate IV: 500-1000 mg (Level C - may offer) 1
  • Dihydroergotamine (DHE): Consider if no contraindications 3, 4

Important Caveat: Limited high-quality data exists for second-line therapy. The evidence supports using medications proven effective as first-line agents rather than switching to unproven alternatives 3.

Adjunctive Therapy

For Nausea/Vomiting

If not using metoclopramide or prochlorperazine as primary therapy, add antiemetics. Nausea itself is disabling and should be treated even without vomiting 5.

To Prevent Recurrence

  • Dexamethasone IV: 10-24 mg (Level B - should offer) 1, 2

This should be given before discharge to reduce 24-72 hour headache recurrence, supported by multiple Class I studies 2.

Supportive Care

  • IV fluids: Normal saline for hydration (though evidence is limited) 6
  • Magnesium sulfate IV: 1-2 g: May help in severe attacks or prevention 4

What NOT to Use

Avoid these medications as first-line therapy:

  • Hydromorphone IV (Level A - must not offer) 1
  • Morphine (Level C - may avoid) 2
  • Paracetamol IV as monotherapy (Level C - should not offer) 1
  • Propofol IV (likely ineffective) 1

The evidence strongly argues against opioids due to lack of efficacy and risk of dependence 2, 7.

Algorithm Summary

  1. Initial Assessment: Confirm migraine diagnosis, check for contraindications (cardiovascular disease for triptans, movement disorders for dopamine antagonists)

  2. First-Line (choose based on availability and patient factors):

    • Prochlorperazine 10 mg IV OR
    • Metoclopramide 10 mg IV OR
    • Ketorolac 30 mg IV OR
    • Sumatriptan 6 mg SC OR
    • GONB (if trained provider available)

  3. Wait 30-60 minutes, reassess pain and nausea

  4. If inadequate response, add second-line agent:

    • Different NSAID if not used initially
    • Chlorpromazine 0.1 mg/kg IV
    • Valproate 500-1000 mg IV

  5. Before discharge, give dexamethasone 10-24 mg IV to prevent recurrence

  6. Discharge planning: Arrange outpatient follow-up, consider preventive therapy if ≥2 attacks/month causing ≥3 days disability 5

Special Populations

Pregnancy: Avoid NSAIDs in third trimester, valproate throughout; metoclopramide is relatively safe 6

Pediatrics: Metoclopramide is first-line; occipital nerve blocks and intranasal lidocaine are second-line options 7

Cardiovascular disease: Avoid triptans and ergotamines; use dopamine antagonists or NSAIDs 6

The strength of this approach lies in the 2025 AHS guideline 1, which represents the most recent and comprehensive evidence synthesis with 12 new Class I studies since 2016, providing the highest level of evidence for ED migraine management.

References

Related Questions

Which intramuscular medication is appropriate for treating acute migraine with nausea in an adult patient in a clinic setting?
What is the adult rapid‑onset three‑drug RUSH protocol for acute migraine treatment, including recommended doses and alternative options?
What is the recommended intravenous (IV) management for an acute severe headache?
What are the recommended injectable treatments for an acute migraine attack, including dosing, contraindications, and alternative options if triptans are unsuitable?
What preventive and acute management should be offered for a patient with weekly migraines?
Which medical specialty performs transcatheter aortic valve replacement (TAVR)?
Can Afrin Extra Strength (oxymetazoline) increase blood pressure?
How should I calculate the Wells or revised Geneva score and use D-dimer results to determine when to order a pulmonary embolism imaging study?
What preoperative recommendations should be followed for a patient with Addison disease (primary adrenal insufficiency) undergoing surgery, including stress-dose glucocorticoid regimen, mineralocorticoid replacement, fluid and electrolyte management, and monitoring?
What are sodium‑glucose co‑transporter‑2 (SGLT2) inhibitors?
Is NPO (nothing by mouth) required before a diagnostic or interventional angiogram?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.